Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Post-market SUrveiLlance RegiStry for the Endogenex System (Endogenex PULSE Registry)
Post-market surveillance registry for the Endogenex System (Endogenex PULSE Registry) with status NOT_YET_RECRUITING, sponsored by Endogenex…
-
CLINICAL_TRIALS trial_result · 2025-09-29Clinical Trial Update: Project MiNT: Assessing the Impact of Food & Video-Based Nutrition Education on Patients With Poorly Controlled Diabetes [NA]
A completed clinical trial assessing the impact of food- and video-based nutrition education on adults with poorly controlled Type 2 diabete…
-
CLINICAL_TRIALS other · 2025-09-29Clinical Trial Update: "Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds" [NA]
A clinical trial update indicates a study on ultrasound-enhanced propolis therapy for healing diabetic foot ulcers is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-26Clinical Trial Update: A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both [Phase 3]
A Phase 3 trial evaluating tirzepatide in pediatric and adolescent participants with Type 2 Diabetes Mellitus inadequately controlled with m…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes [NA]
This clinical trial update outlines a multicenter, randomized, open-label study comparing Cofrogliptin to acarbose in drug-naïve patients wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Health Literacy Levels of Patients Living With Type 2 Diabetes and Multi-disease and Their Families Using HLQTM
A clinical trial enrolling to assess health literacy levels in people with Type 2 diabetes and other conditions, and their families, using t…
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: Game-Based Education and Treatment Adherence in Type 2 Diabetes [NA]
A completed clinical trial evaluating a game-based education program to improve treatment adherence in people with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2025-09-25Clinical Trial Update: Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) [Phase 3]
The PROMINENT phase 3 trial evaluating pemafibrate in adults with type 2 diabetes and dyslipidemia was terminated and results have been post…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: DIgitAl diabeTES Treatment - the Healthy Eating, heaLthy Patients Trial [NA]
A clinical trial from Linköping University is recruiting for a digital diabetes treatment study called Healthy Eating, Healthy Patients targ…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 clinical trial investigating HDM1002 tablets for type 2 diabetes mellitus is currently recruiting.
-
CLINICAL_TRIALS other · 2025-09-25Clinical Trial Update: A Study on the Short - Course Treatment Regimen Containing Pretomanid for Diabetes Mellitus Complicated With Rifampicin - Resistant/Multidrug - Resistant Pulmonary Tuberculosis
Clinical trial update on a short-course pretomanid-containing regimen for rifampicin-resistant/multidrug-resistant pulmonary tuberculosis in…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Japan, as Part of Local Clinical Practice
This completed clinical trial evaluated how oral semaglutide performs in adults with type 2 diabetes in Japan as part of routine clinical pr…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Denmark, as Part of Local Clinical Practice
A completed clinical trial in Denmark evaluating how oral semaglutide works in people with type 2 diabetes as part of local clinical practic…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Sweden, as Part of Local Clinical Practice
A completed study conducted in Sweden evaluated how oral semaglutide works in people with type 2 diabetes as part of local clinical practice…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice
A completed study in Mexico investigated how oral semaglutide works in people with type 2 diabetes as part of local clinical practice.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in the United Kingdom, as Part of Local Clinical Practice
A completed UK clinical trial assessed how oral semaglutide behaves in people with type 2 diabetes as part of local clinical practice.
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice
A completed clinical trial update describing how oral semaglutide is studied in people with Type 2 diabetes in the Netherlands as part of lo…
-
CLINICAL_TRIALS withdrawal · 2025-09-24Clinical Trial Update: A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes [Phase 2]
A Phase 2 trial evaluating bimagrumab and tirzepatide, alone or in combination, in adults with obesity or overweight with Type 2 diabetes, h…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: Glycemia and Antibiotic Efficacy in Diabetic Recurrent UTIs [NA]
A completed study evaluating the relationship between glycemic control and antibiotic efficacy in individuals with type 2 diabetes mellitus …
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Saudi Arabia, as Part of Local Clinical Practice
A completed clinical trial in Saudi Arabia evaluating how oral semaglutide works in adults with type 2 diabetes as part of local clinical pr…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Spain, as Part of Local Clinical Practice
This completed Spanish study evaluated how oral semaglutide behaves in adults with type 2 diabetes as part of local clinical practice.
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: Effects of Different Early Intensive Therapies on Long-term β-cell Function [Phase 4]
This update notes the completion of a Phase 4 clinical trial investigating how different early intensive therapies impact long-term beta-cel…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Italy, as Part of Local Clinical Practice
A completed clinical trial update examining how oral semaglutide works in adults with type 2 diabetes in Italy as part of routine clinical p…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant [Phase 1]
Phase 1 clinical trial evaluating the safety, tolerability, and drug levels of an Exenatide implant for overweight/obesity and type 2 diabet…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D [Phase 1]
A Phase 1 pharmacokinetics study of NEX-22A in adults with Type 2 diabetes mellitus has completed.